AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Cherry AG

Investor Presentation Mar 16, 2022

730_ip_2022-03-16_0402dcfe-183a-4946-b277-be8decd2d033.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

BERENBERG EU OPPORTUNITIES

Investor Presentation – March 16, 2022

BUSINESS AREA GAMING

THE CHERRY MX HISTORY

Innovation & Quality "Made In Germany"

THE CHERRY MX HISTORY

Innovation & Quality "Made In Germany"

11

EU Opportunities - March 16, 2022 12

ROG Strix Scope RGB Mechanical

Keyboard, ROG/Asus

"CHERRY INSIDE"

OMEN/HP

Distinguishes customer products

to achieve premium pricing

THE AWARD-WINNING SERIES – AESTHETICS MEETS GERMAN ENGINEERING CHERRY MX 2.0S, HC 2.2 and MC 2.1.

BUSINESS AREA PROFESSIONAL

  • State-of-the-art card terminal solution for workplaces in German healthcare telematics infrastructure

  • Approved by gematik GmbH and introduced for all service providers in the German healthcare system
  • iF Design Award 2021 in the category of medical devices

  • Clinics/hospitals
  • pharmacies
  • dentist and doctor offices
  • Continuously new customer groups added

  • High-resolution color display enables optimal readability and intuitive operation

  • Easily disinfectable touchscreen glass surface for hygiene
  • Optional patient PIN-Pad (PP-1516) can be easily connected via USB (launch 2022)
  • Can be operated without a power supply via Power-Over-Ethernet
  • Prepared for reading contactless cards by NFC interface

EU Opportunities - March 16, 2022 18

IN €M/
AS INDICATED
FY 2020* 9M 2021 FORECAST FY 2021
Revenue 130.2 123.4 around 170
EBITDA margin
(adj.)
28.5% 29.6% around 30%
IN €M/
AS INDICATED
ANALYST CONSENSUS
Revenue 168.8
EBITDA marqin 26.7%
Components +++
Gaming Devices ++
Peripherals ++
Digital Health +++
  • Underlying multiple growth drivers and mega trends support mid- and long-term growth
  • Supply chain disruptions, particularly in China, and temporary fluctuations in the ordering behavior of customers expected to continue in H1/2022
  • Investments in organic growth will be reflected by somewhat subdued profitability margins in FY 2022
  • No direct exposure to Russia or Ukraine

STRATEGIC ELEMENTS FOR ORGANIC GROWTH

  • Expand global innovation leader position
  • Develop products at the edge of technology
  • Expand leading premium brand presence
  • Deepen global market penetration

INORGANIC GROWTH STRATEGY / M&A

  • Focus on 4 existing business units
  • Complementary products and markets
  • Increase geographical strength
  • Synergies for market access / sales channels

OPERATIONAL MEASURES FOR ORGANIC GROWTH

  • Increase number, knowledge and expertise of employees
  • Advanced innovation & development activities
  • Expand marketing activities in B-2-B and B-2-C markets
  • Increase capacity and degree of automation in production

M&A TARGET PROFILE

  • Geographic: USA, Europe, Asia
  • Revenue: EUR 15m EUR 35m
  • EBITDA / EBIT margins: double digit (%)
  • Product areas: complementary products e. g. headsets, mice, video collaboration, microphones, other peripherals, ergonomic devices, etc.

Date Detail
March 31 Publication Annual Financial Report
April 4 - 5 US Roadshow (virtual)
April 7 MicroCap Days 2022
May 11 Publication Quarterly Financial Report (call-date Q1)
May 12 - 13 Stockpicker Summit
May 23 - 25 Equity Forum
June 8 Annual General Meeting
August 11 Publication Half-yearly Financial Report
September 5 – 6 Equity Forum
November 15 Publication Quarterly Financial Report (call-date Q3)
November 16 Münchner Kapitalmarkt Konferenz
November 28 - 30 Eigenkapitalforum

Talk to a Data Expert

Have a question? We'll get back to you promptly.